Ann: NWR Virtual Healthcare Conference, page-8

First 8 Last

Share
Profile

Follow
daveg

2,297 Posts.

230

21/03/23

10:55

Post #: 66874686
Share

Originally posted by synaphai: ↑

Wayne provided lot of new info. My summary:

7 sites for the EFS. Each site has a review board that must approve the trial before it can go forward at that site. Currently 2 sites have finished their review and have initiated the patient identification process. Full enrollment of the 15 patients is expected by late June. Then we'll get 30 day data with plans to present that data at the TCT conference in late October.

Anteris should receive $25,000 USD for each device used in the EFS. So not much in total but the pivotal trial will include many more patients and will generate up to $27.5 million USD in revenue depending on the number of patients enrolled.

The pivotal trial is expected to enroll from 500 to 1100 patients. Wayne thinks it can be enrolled in a year, which would mean that the trial will take 2 years (each patient will be followed for a year).

He thinks valve-in-valve can get FDA approval earlier, with revenue in 2024-25. I'm skeptical but he said more info should be forthcoming at the AGM.

Expand

Thank you for the summary...must the 30day data be reported as soon as it is compiled and collated...aka end of July approx.

AVR Price at posting: $19.50 Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

ASX Market Close: New week sees local bourse snaps 2-day losing streak | July 28

Monday's HotCopper trends: Boss guidance, Botanix quarterly | July 28

Clarity confidence – and share price – up on bumper $203M institutional placement

Listen: HotCopper Wire Podcast 019 – Dreaming of the 9,000s

BOE

Boss tanks -42% after quietly flagging 'potential challenges' for Honeymoon

First 8 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $5.05		Change 0.200(4.12%)		Mkt cap ! $78.29M

Open	High	Low	Value	Volume
$4.86	$5.05	$4.86	$32.22K	6.421K

Buyers (Bids)

No.	Vol.	Price($)
1	454	$4.86

Sellers (Offers)

Price($)	Vol.	No.
$5.05	887	2

View Market Depth

No.	Vol.	Price($)
1	454	4.860
2	2144	4.850
1	882	4.840
1	209	4.780
1	1000	4.750

Price($)	Vol.	No.
5.050	887	2
5.070	200	1
5.150	1212	1
5.200	2136	2
5.220	2066	1

Last trade - 15.32pm 28/07/2025 (20 minute delay)

AVR (ASX) Chart

Ann: NWR Virtual Healthcare Conference, page-8

ASX Market Close: New week sees local bourse snaps 2-day losing streak | July 28

Monday's HotCopper trends: Boss guidance, Botanix quarterly | July 28

Clarity confidence – and share price – up on bumper $203M institutional placement

Listen: HotCopper Wire Podcast 019 – Dreaming of the 9,000s

Boss tanks -42% after quietly flagging 'potential challenges' for Honeymoon

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: NWR Virtual Healthcare Conference, page-8

Top Stories

ASX Market Close: New week sees local bourse snaps 2-day losing streak | July 28

Monday's HotCopper trends: Boss guidance, Botanix quarterly | July 28

Clarity confidence – and share price – up on bumper $203M institutional placement

Listen: HotCopper Wire Podcast 019 – Dreaming of the 9,000s

Boss tanks -42% after quietly flagging 'potential challenges' for Honeymoon

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News